These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The role of SIRT2 in vascular-related and heart-related diseases: A review. Wu B; You S; Qian H; Wu S; Lu S; Zhang Y; Sun Y; Zhang N J Cell Mol Med; 2021 Jul; 25(14):6470-6478. PubMed ID: 34028177 [TBL] [Abstract][Full Text] [Related]
7. PHD Finger Protein 19 Promotes Cardiac Hypertrophy via Epigenetically Regulating SIRT2. Gu W; Cheng Y; Wang S; Sun T; Li Z Cardiovasc Toxicol; 2021 Jun; 21(6):451-461. PubMed ID: 33611744 [TBL] [Abstract][Full Text] [Related]
8. CSN6 aggravates Ang II-induced cardiomyocyte hypertrophy via inhibiting SIRT2. Mei ZL; Wang HB; Hu YH; Xiong L Exp Cell Res; 2020 Nov; 396(1):112245. PubMed ID: 32882218 [TBL] [Abstract][Full Text] [Related]
9. Emerging roles of Sirtuin 2 in cardiovascular diseases. Taneja A; Ravi V; Hong JY; Lin H; Sundaresan NR FASEB J; 2021 Oct; 35(10):e21841. PubMed ID: 34582046 [TBL] [Abstract][Full Text] [Related]
10. The role of sirtuins in cardiac disease. Matsushima S; Sadoshima J Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1375-89. PubMed ID: 26232232 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial sirtuins in the heart. Bugger H; Witt CN; Bode C Heart Fail Rev; 2016 Sep; 21(5):519-28. PubMed ID: 27295248 [TBL] [Abstract][Full Text] [Related]
12. Sirtuin-2 mediates male specific neuronal injury following experimental cardiac arrest through activation of TRPM2 ion channels. Shimizu K; Quillinan N; Orfila JE; Herson PS Exp Neurol; 2016 Jan; 275 Pt 1(Pt 1):78-83. PubMed ID: 26522013 [TBL] [Abstract][Full Text] [Related]
13. Versatile role of sirtuins in metabolic disorders: From modulation of mitochondrial function to therapeutic interventions. Afzaal A; Rehman K; Kamal S; Akash MSH J Biochem Mol Toxicol; 2022 Jul; 36(7):e23047. PubMed ID: 35297126 [TBL] [Abstract][Full Text] [Related]
14. Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway. Xu M; Xue RQ; Lu Y; Yong SY; Wu Q; Cui YL; Zuo XT; Yu XJ; Zhao M; Zang WJ Cardiovasc Res; 2019 Mar; 115(3):530-545. PubMed ID: 30165480 [TBL] [Abstract][Full Text] [Related]
15. SIRT4 accelerates Ang II-induced pathological cardiac hypertrophy by inhibiting manganese superoxide dismutase activity. Luo YX; Tang X; An XZ; Xie XM; Chen XF; Zhao X; Hao DL; Chen HZ; Liu DP Eur Heart J; 2017 May; 38(18):1389-1398. PubMed ID: 27099261 [TBL] [Abstract][Full Text] [Related]